Medivation (MDVN) Preclinical Excitement Seems To Be Bearing Fruit - Stifel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Medivation (MDVN) Preclinical Excitement Seems To Be Bearing Fruit - Stifel

Medivation Announces Presentation of Phase I Talazoparib Combination Data in Several Advanced Cancers

April 17, 2016 5:30 PM EDT

SAN FRANCISCO, CA -- (Marketwired) -- 04/17/16 --

Medivation, Inc. (NASDAQ: MDVN) today announced that Phase I data from its investigational agent talazoparib, a highly-potent PARP inhibitor, was presented at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans by the study's lead investigator Zev A. Wainberg, M.D., Associate Professor of Medicine at the University of California Los Angeles (UCLA) and Co-Director of the UCLA GI Oncology Program, during a Clinical Trials Mini-Symposium. The primary objective of the study was to determine the maximum tolerated dose (MTD) of talazoparib... More